Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-06-23

Clinical Trial Update: Levetiracetam: The Anti-Convulsant of Choice for Elderly Patients With Dementia [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating levetiracetam as a convulsant therapy for elderly patients with dementia-related epilepsy; study completed with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

Sponsor: Drexel University College of Medicine | Conditions: Epilepsy | Phase 4 | Status: COMPLETED | Results posted: 2015-06-23